Prognostic factors for cancer‐specific survival in 220 patients with breast cancer: A single center experience

OBJECTIVES: Hospital‐based breast cancer survival studies are scarce in western Iran. Furthermore, the relationship between breast cancer survival and clinical parameters has been extensively studied, but many of the findings come from developing countries. This paper aims to estimate the survival of hospital‐based breast cancer patients and its predictor factors. METHOD: This retrospective analysis was conducted on 578 patients with primary breast cancer who underwent surgery between 2004 and 2020. Information was collected from medical reports by the Hospital information system in Imam Reza Hospital, Kermanshah, Iran. One‐, 2‐, 5‐, and 10‐year breast cancer‐specific survival has been calculated using the Kaplan–Meier process. Crude and adjusted Hazard Ratios (HR) were calculated using the Cox proportional regression model. RESULT: One‐, 2‐, and 5‐year overall breast cancer survival were 219 (99.54%), 196 (89.09%), 159 (72.27%), and 70 (31.81%), respectively. Univariate analysis of breast cancer patients with tumor‐related variables revealed that factors such as age, menopause status, lymph node metastasis, number of lymph nodes, organ metastasis, and stage of disease were significantly associated with disease‐specific survival (p < .05). Multivariate analysis demonstrated that metastasis (HR = 41.77, 95% CI: 15.3–114.15) and lymph node metastasis (HR = 5.26, 95% CI: 1.9–14.6) were significantly related to survival. CONCLUSION: The findings demonstrate that survival is relatively low and is consistent with late‐stage disease diagnosis. It is believed that this is due to a poor level of awareness, lack of screening programs, and subsequent late access to treatment.